Brief: Immunovant Announces Proposed Offering Of $300 Million Of Common Stock
Sept 26 (Reuters) - Immunovant Inc IMVT.O :
* IMMUNOVANT ANNOUNCES PROPOSED OFFERING OF $300 MILLION OF
COMMON
STOCK
* IMMUNOVANT INC - INTENDS TO OFFER AND SELL $130 MILLION OF
SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING
* IMMUNOVANT INC - INTENDS TO SELL $170 MILLION OF SHARES OF
ITS
COMMON STOCK TO ROIVANT SCIENCES LTD. IN A PRIVATE PLACEMENT
Source text for Eikon: ID:nGNX1Bwypr
Further company coverage: IMVT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million